Researchers map the uncertain path after leukemia drugs fail
NCT ID NCT05621148
Summary
This study looked back at the medical records of 152 adults with chronic lymphocytic leukemia (CLL) to understand what happens after two common types of oral medications stop working. The goal was to see what treatments doctors tried next and how patients responded, because there is no established standard of care for this situation. The research aims to fill a knowledge gap to help guide future treatment decisions for patients who have run out of effective oral drug options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bordeaux Pessac
Pessac, 33604, France
-
CHU Estaing - Hématologie Clinique Adulte
Clermont-Ferrand, 63000, France
-
Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
-
Centre Léon Bérard - Hématologie
Lyon, 69373, France
-
Institut Paoli-Calmettes - Hématologie Clinique
Marseille, 13273, France
-
MONTPELLIER - Hôpital Saint-Eloi - Hématologie Clinique
Montpellier, 34295, France
-
Strasbourg - Icans
Strasbourg, 67033, France
-
Toulouse - IUCT Oncopole - Service d'Hématologie
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.